134 related articles for article (PubMed ID: 15052519)
1. Galactorrhea due to psychotropic drugs.
Kropp S; Ziegenbein M; Grohmann R; Engel RR; Degner D
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S84-8. PubMed ID: 15052519
[TBL] [Abstract][Full Text] [Related]
2. Cardiac adverse effects associated with psychotropic drugs.
Schmid C; Grohmann R; Engel RR; Rüther E; Kropp S
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S65-9. PubMed ID: 15052516
[TBL] [Abstract][Full Text] [Related]
3. The AMSP drug safety program: methods and global results.
Grohmann R; Engel RR; Rüther E; Hippius H
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S4-11. PubMed ID: 15052509
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.
Lange-Asschenfeldt C; Grohmann R; Lange-Asschenfeldt B; Engel RR; Rüther E; Cordes J
J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904
[TBL] [Abstract][Full Text] [Related]
5. Blood dyscrasias induced by psychotropic drugs.
Stübner S; Grohmann R; Engel R; Bandelow B; Ludwig WD; Wagner G; Müller-Oerlinghausen B; Möller HJ; Hippius H; Rüther E
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S70-8. PubMed ID: 15052517
[TBL] [Abstract][Full Text] [Related]
6. Severe and uncommon involuntary movement disorders due to psychotropic drugs.
Stübner S; Rustenbeck E; Grohmann R; Wagner G; Engel R; Neundörfer G; Möller HJ; Hippius H; Rüther E
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S54-64. PubMed ID: 15052515
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study.
Grohmann R; Engel RR; Geissler KH; Rüther E
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S27-38. PubMed ID: 15052512
[TBL] [Abstract][Full Text] [Related]
8. The AMUP study for drug surveillance in psychiatry - a summary of inpatient data.
Grohmann R; Hippius H; Helmchen H; Rüther E; Schmidt LG
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S16-26. PubMed ID: 15052511
[TBL] [Abstract][Full Text] [Related]
9. Adverse psychic reactions to psychotropic drugs--a report from the AMUP study.
Grohmann R; Ströbel C; Rüther E; Dirschedl P; Helmchen H; Hippius H; Müller-Oerlinghausen B; Schmidt LG; Wolf B
Pharmacopsychiatry; 1993 May; 26(3):84-93. PubMed ID: 8415899
[TBL] [Abstract][Full Text] [Related]
10. Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics.
Bender S; Grohmann R; Engel RR; Degner D; Dittmann-Balcar A; Rüther E
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S46-53. PubMed ID: 15052514
[TBL] [Abstract][Full Text] [Related]
11. Adverse drug reactions of antidepressants and antipsychotics: experience, knowledge and attitudes among Norwegian psychiatrists.
Castberg I; Reimers A; Sandvik P; Aamo TO; Spigset O
Nord J Psychiatry; 2006; 60(3):227-33. PubMed ID: 16720514
[TBL] [Abstract][Full Text] [Related]
12. Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland.
Greil W; Häberle A; Schuhmann T; Grohmann R; Baumann P
Swiss Med Wkly; 2013; 143():w13772. PubMed ID: 23821346
[TBL] [Abstract][Full Text] [Related]
13. Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 2015.
Glocker C; Grohmann R; Engel R; Seifert J; Bleich S; Stübner S; Toto S; Schüle C
Eur Arch Psychiatry Clin Neurosci; 2021 Dec; 271(8):1425-1435. PubMed ID: 33768297
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
Jha N; Bajracharya O; Namgyal T
Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
[TBL] [Abstract][Full Text] [Related]
15. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
Curran S; Turner D; Musa S; Wattis J
Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
[TBL] [Abstract][Full Text] [Related]
16. Are non-serious adverse reactions to psychiatric drugs really non-serious?
Pozzi M; Bertella S; Cattaneo D; Molteni M; Perrone V; Carnovale C; Antoniazzi S; Clementi E; Radice S
J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):394-400. PubMed ID: 23952186
[TBL] [Abstract][Full Text] [Related]
17. Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project.
Stübner S; Padberg F; Grohmann R; Hampel H; Hollweg M; Hippius H; Möller HJ; Rüther E
J Clin Psychiatry; 2000 Aug; 61(8):569-74. PubMed ID: 10982199
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergic activity of commonly prescribed medications and neuropsychiatric adverse events in older people.
Nishtala PS; Fois RA; McLachlan AJ; Bell JS; Kelly PJ; Chen TF
J Clin Pharmacol; 2009 Oct; 49(10):1176-84. PubMed ID: 19783711
[TBL] [Abstract][Full Text] [Related]
19. Research methods in drug surveillance.
Engel RR; Grohmann R; Rüther E; Hippius H
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S12-5. PubMed ID: 15052510
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacovigilance as new direction of research].
Gaszner G; Makkos Z; Gaszner P
Neuropsychopharmacol Hung; 2005 Dec; 7(4):194-8. PubMed ID: 16496484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
